866-997-4948(US-Canada Toll Free)

Hematocrit Test Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Nov 2018

Category :

Medical Equipments

No. of Pages : 170 Pages

Hematocrit Test Devices Market - Overview

This report studies the current as well as future prospects of the global hematocrit test devices market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hematocrit test devices and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global hematocrit test devices market in terms of product, end-user, and region.

The global hematocrit test devices market has been segmented based on product, end-user and region. In terms of product, the global market has been classified into blood analyzers, hematocrit test meter, and others. The others segment comprises reagents and accessories. Based on end-user, the global hematocrit test devices market has been segmented into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals & ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period.

Bottom-up approach has been employed for determining the size of the global hematocrit test devices  market, using various market indicators obtained from secondary sources, which include analysis of launched products and mapping of sale of hematocrit test devices of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein revenue of all publicly listed market players was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market size and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global hematocrit test devices market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. Competitive scenario existing among the market players has been evaluated through market share analysis in the competitive landscape section of the report. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global hematocrit test devices market. The report also comprises major mergers & acquisitions, reimbursement scenario by region/global market, epidemiological overview of blood related disease diseases, and key launches & approvals.

In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. Competitive landscape section of the report provides analysis of market share of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drug eluting balloon market.

Major players operating in the global hematocrit test devices market are Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers, EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics.

The global hematocrit test devices market has been segmented as follows:

Global Hematocrit Test Devices Market, by Product

  • Blood Analyzers
  • Hematocrit Test Meters
  • Others

Global Hematocrit Test Devices Market, by End-user

  • Hospitals & Ambulatory Surgical Centers
  • Clinics
  • Diagnostic & Pathology Labs
  • Others

Global Hematocrit Test Devices Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hematocrit Test Devices Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities

5. Market Outlook
5.1.Prevalence of Anemia among pregnant women by key countries
5.2. Prevalence of Anemia by global and WHO region
5.3. Key Mergers & Acquisitions
5.4.Recent Product Launches and Approval
5.5.Comparative Analysis of Hematocrit Test Method
5.6.Epidemiological Overview of blood related Disease

6. Global Hematocrit Test Devices Market Analysis and Forecasts, by Product 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Blood Analyzers
6.3.2. Hematocrit Test Meters
6.3.3. Others 
6.4. Market Attractiveness, by Product

7. Global Hematocrit Test Devices Market Analysis and Forecasts, by End-user 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals & Ambulatory Surgical Centers
7.3.2. Clinics 
7.3.3. Diagnostic & Pathology Labs
7.3.4. Others 
7.4. Market Attractiveness, by End-user

8. Global Hematocrit Test Devices Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America 
8.2.2. Europe 
8.2.3. Asia Pacific 
8.2.4. Latin America 
8.2.5. Middle East & Africa 
8.3. Market Attractiveness, by Country/Region

9. North America Hematocrit Test Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016–2026
9.2.1. Blood Analyzers
9.2.2. Hematocrit Test Meters
9.2.3. Others 
9.3. Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals & Ambulatory Surgical Centers
9.3.2. Clinics 
9.3.3. Diagnostic & Pathology Labs
9.3.4. Others 
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis 
9.5.1. By Product 
9.5.2. By End-user 
9.5.3. By Country

10. Europe Hematocrit Test Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Blood Analyzers
10.2.2. Hematocrit Test Meters
10.2.3. Others 
10.3. Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals & Ambulatory Surgical Centers
10.3.2. Clinics 
10.3.3. Diagnostic & Pathology Labs
10.3.4. Others 
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis 
10.5.1. By Product 
10.5.2. By End-user 
10.5.3. By Country/Sub-region

11. Asia Pacific Hematocrit Test Devices Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Blood Analyzers
11.2.2. Hematocrit Test Meters
11.2.3. Others 
11.3.Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals & Ambulatory Surgical Centers
11.3.2. Clinics 
11.3.3. Diagnostic & Pathology Labs
11.3.4. Others 
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis 
11.5.1. By Product 
11.5.2. By End-user 
11.5.3. By Country/Sub-region

12. Latin America Hematocrit Test Devices Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Blood Analyzers
12.2.2. Hematocrit Test Meters
12.2.3. Others 
12.3.Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals & Ambulatory Surgical Centers
12.3.2. Clinics 
12.3.3. Diagnostic & Pathology Labs
12.3.4. Others 
12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis 
12.5.1. By Product 
12.5.2. By End-user 
12.5.3. By Country/Sub-region

13. Middle East & Africa Hematocrit Test Devices Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Blood Analyzers
13.2.2. Hematocrit Test Meters
13.2.3. Others 
13.3.Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals & Ambulatory Surgical Centers
13.3.2. Clinics 
13.3.3. Diagnostic & Pathology Labs
13.3.4. Others 
13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis 
13.5.1. By Product 
13.5.2. By End-user 
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1.Market Player - Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. NIHON KOHDEN CORPORATION
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Product Portfolio
14.4.1.3. SWOT Analysis
14.4.1.4. Strategic Overview
14.4.1.5. Financial Overview
14.4.2. F. Hoffmann-La Roche Ltd
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Product Portfolio
14.4.2.3. SWOT Analysis
14.4.2.4. Strategic Overview
14.4.2.5. Financial Overview
14.4.3. Danaher Corporation
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Product Portfolio
14.4.3.3. SWOT Analysis
14.4.3.4. Strategic Overview
14.4.3.5. Financial Overview
14.4.4. Siemens Healthineers (Siemens AG)
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Product Portfolio
14.4.4.3. SWOT Analysis
14.4.4.4. Strategic Overview
14.4.4.5. Financial Overview
14.4.5. EKF Diagnostics Holdings plc
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Product Portfolio
14.4.5.3. SWOT Analysis
14.4.5.4. Strategic Overview
14.4.5.5. Financial Overview
14.4.6. Sysmex Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Product Portfolio
14.4.6.3. SWOT Analysis
14.4.6.4. Strategic Overview
14.4.6.5. Financial Overview
14.4.7. Nova Biomedical
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Product Portfolio
14.4.7.3. SWOT Analysis
14.4.7.4. Strategic Overview
14.4.7.5. Financial Overview
14.4.8. Abbott Laboratories
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Product Portfolio
14.4.8.3. SWOT Analysis
14.4.8.4. Strategic Overview
14.4.8.5. Financial Overview
14.4.9. HORIBA, Ltd.
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Product Portfolio
14.4.9.3. SWOT Analysis
14.4.9.4. Strategic Overview
14.4.9.5. Financial Overview
14.4.10. Boule Diagnostics 
14.4.6.10. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Product Portfolio
14.4.10.3. SWOT Analysis
14.4.10.4. Strategic Overview
14.4.10.5. Financial Overview

15. Competition Landscape

List of Table

Table 1: Prevalence of Anemia among Pregnant Women, by Key Countries 
Table 2: Prevalence of anemia among children aged 6-59 months according to Global and WHO region
Table 3: Prevalence of Anemia among all women of reproductive age (15-49) years according to Global and WHO region
Table 4: Comparative Analysis of Hematocrit Test Methods
Table 5: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016-2026
Table 6: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 10: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 15: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 16: Asia Pacific Hematocrit Test Devices Market value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 20: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
Table 21: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Chart

Figure 1: Global Hematocrit Test Devices Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026 
Figure 2: Global Hematocrit Test Devices Market (US$ Mn), by Key Segment, 2017 
Figure 3: Global Hematocrit Test Devices Market (US$ Mn), by Key Segment and Market Share (%), 2017 Figure 4: Global Hematocrit Test Devices Market (US$ Mn), by Market Share (%), 2017
Figure 5: Global Hematocrit Test Devices Market (US$ Mn), by Region (%), 2017 
Figure 6: Global Hematocrit Test Devices, Market Opportunity Map, by Product
Figure 7: Global Hematocrit Test Devices, Market Opportunity Map, by End-user 
Figure 8: Key Industry Evolution/Developments 
Figure 9: Global Hematocrit Test Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026 
Figure 10: Merger and Acquisition of major player from 2010–2018 
Figure 11: Recent Product Launches and Approval 
Figure 12: Annual number of Congenital Heart Defects births in different region 
Figure 13: Estimated Global Prevalence of Chronic Kidney Disease
Figure 14: Estimated Global Prevalence of Leukemia  
Figure 15: Global Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 16: Global Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 17: Global Hematocrit Test Devices Market Value Share, by Blood Analyzer Segment, 2016-2026 Figure 18: Global Hematocrit Test Devices Market Value Share, by Hematocrit Test Meters Segment, 2016-2026 
Figure 19: Global Hematocrit Test Devices Market Value Share, by Others, 2016-2026 
Figure 20: Global Hematocrit Test Market Value Share, by End-user, 2017 and 2026
Figure 21: Global Hematocrit Test Market Attractiveness, End-user 2018–2026 
Figure 22: Global Hematocrit Test Market Value Share, by Hospitals & Ambulatory Surgical Centers Segment, 2016-2026 
Figure 23: Global Hematocrit Test Market Value Share, by Clinics Segment, 2016-2026 
Figure 24: Global Hematocrit Test Market Value Share, by Diagnostic & Pathology Labs, 2016-2026 
Figure 25: Global Hematocrit Test Market Value Share, by Others, 2016-2026 
Figure 26: Global Hematocrit Test Devices Market Value Share, by Region, 2017 and 2026 
Figure 27: Global Hematocrit Test Devices Market Attractiveness, Region 
Figure 28: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 29: North America Hematocrit Test Devices Market Value Share, by Country, 2017 and 2026 
Figure 30: North America Hematocrit Test Devices Market Attractiveness, by Country, 2018–2026 
Figure 31: North America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 32: North America Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 33: North America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 
Figure 34: North America Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026 
Figure 35: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026 
Figure 36: Europe Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 37: Europe Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 38: Europe Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 39: Europe Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 40: Europe Hematocrit Test Devices Balloons Market Value Share, by End-user, 2017 and 2026 Figure 41: Europe Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026
Figure 42: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026 
Figure 43: Asia Pacific Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 44: Asia Pacific Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026
Figure 45: Asia Pacific Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 46: Asia Pacific Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026 
Figure 47: Asia Pacific Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 
Figure 48: Asia Pacific Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026 
Figure 49: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026 
Figure 50: Latin America Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 
Figure 51: Latin America Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026 Figure 52: Latin America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 53: Latin America Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026 
Figure 54: Latin America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026
Figure 55: Latin America Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026 
Figure 56: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026 
Figure 57: Middle East & Africa Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 
Figure 58: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026 
Figure 59: Middle East & Africa Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 Figure 60: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
Figure 61: Middle East & Africa Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 Figure 62: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026 Figure 63: Global Hematocrit Test Devices Market, Company Share Analysis 
Figure 64: EKF Diagnostics Holdings plc. , Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 65: EKF Diagnostics Holdings plc, Research and Development Expenses, 2013-2017 
Figure 66: EKF Diagnostics Holdings Plc, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 67: EKF Diagnostics Holdings plc. , Breakdown of Net Sales (% Share), by Region (2017 
Figure 68 Sysmex Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 69: Sysmex Corporation, Research and Development Expenses, 2013-2017 
Figure 70: Sysmex Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 71: Sysmex Corporation, Breakdown of Net Sales (% Share), by Region (2017
Figure 72 Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 73: Abbott Laboratories, Research and Development Expenses, 2013-2017 
Figure 74: Abbott Laboratories, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 75: Abbott Laboratories, Breakdown of Net Sales (% Share), by Region (2017)
Figure 76: Nihon Kohden Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 77: Nihon Kohden Corporation, Research and Development Expenses, 2013-2017 
Figure 78: Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 79: Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Region (2017)
Figure 80: F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 81: F. Hoffmann-La Roche Ltd., Research and Development Expenses, 2013-2017 
Figure 82: F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 83: F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Region (2017)
Figure 84: Danaher Corporation., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 85: Danaher Corporation, Research and Development Expenses, 2013-2017 
Figure 86: Danaher Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 87: Danaher Corporation, Breakdown of Net Sales (% Share), by Region (2017)
Figure 88: Siemens Healthineers (Siemens AG), Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 89: Siemens Healthineers (Siemens AG), Research and Development Expenses, 2013-2017 
Figure 90: Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 91: Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Region (2017)
Figure 92: HORIBA, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 93: HORIBA, Ltd., Research and Development Expenses, 2013-2017 
Figure 94: HORIBA, Ltd., Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 95: HORIBA, Ltd., Breakdown of Net Sales (% Share), by Region (2017)
Figure 96: Boule Diagnostics, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 97: Boule Diagnostics, Research and Development Expenses, 2013-2017 
Figure 98: Boule Diagnostics, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 99: Boule Diagnostics, Breakdown of Net Sales (% Share), by Region (2017)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *